• Explore /
  • Poster
  • / A single-arm, multi-institutional, phase 2 study of a pembrolizumab-based organ preservation strategy for locally advanced larynx cancers: SMART-KEY (LACOG 0720) trial.

A single-arm, multi-institutional, phase 2 study of a pembrolizumab-based organ preservation strategy for locally advanced larynx cancers: SMART-KEY (LACOG 0720) trial.

Abstract Poster

Authors

null

Thiago Bueno Oliveira Sr.

A.C. Camargo Cancer Center, São Paulo, Brazil

Thiago Bueno Oliveira Sr., Flavio Augusto Ferreira da Silva , Tatiane Motta , Andrea Juliana Gomes , Iane Pinto Figueiredo Lima , Fernanda Bohns Pruski Ramos , Luiz Henrique de Lima Araujo , Milena Perez Mak , Kathia Cristina Abdalla , Gustavo Nader Marta , Marcos Antonio Santos , Rafaela Gomes de Jesus , Gustavo Werutsky , Taiane Francieli Rebelatto , William Nassib William Jr.

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT04943445

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS6111)

DOI

10.1200/JCO.2023.41.16_suppl.TPS6111

Abstract #

TPS6111

Poster Bd #

98a

Abstract Disclosures

Similar Posters

First Author: Xiuning Le

First Author: Mario Javier Pineda

First Author: Robert A. Ramirez

First Author: Salma K. Jabbour